Amoneta Diagnostics - Amoneta DiagnosticsAmoneta DiagnosticsAmoneta Diagnostics

  • Products
    • APO-Easy®
    • NeuroDeGene®
    • MemoryLinc®
    • NeuroLINCs
  • Projects
  • About Us
  • News & Events
  • Contact Us

Team

Amoneta Diagnostics > Team
Project Manager

Céline MEYER

Senior Scientist

Miguel CASANOVA

President & Chief Scientific Officer

Hüseyin FIRAT

Chief Executive Officer

Stéphanie BOUTILLIER

Empowering clinicians, healthcare professionals, and drug developers with innovative biomarkers for precise characterization of patients with neurodegenerative disorders.
Contact us
Know more about us

Products

  • APO-Easy®
  • NeuroDeGene®
  • MemoryLinc®
  • NeuroLINCs

useful links

  • Products
  • Projects
  • About Us
  • News & Events
  • Contact Us
  • Instructions for Use

RECENT POSTS

  • Amoneta Diagnostics at AD/PD™ 2025: APO-Easy® Genotyping kit in the Context of New Therapies’ LaunchMarch 27, 2025
  • “Meet&Match” BiovalleyOur CEO speaks on Gender and Genetics at “Meet&Match” event in StrasbourgDecember 9, 2024
Copyright © 2026 Amoneta Diagnostics. All rights reserved.